Entrada Therapeutics, Inc. (TRDA) income statement
TRDANasdaqPharmaceutical PreparationsFiscal year ends December 31
$5.03+0.07 (+1.41%)
Close on Nov 18, 2026Market cap $195.85MP/E –Yield –
Entrada Therapeutics, Inc. financial ratios
See a number that looks wrong?